CATEGORIES

IVI, ST Pharm exchange MoU,

clinical development of COVID-19 vaccine

Pharmaniaga strives to develop children’s hexavalent vaccine by 2023

Pharmaniaga LifeScience Sdn Bhd PLS), a wholly-owned subsidiary of Malaysia’s leading pharmaceutical company

Alliance Pharma unveils state-of-the-art

bioanalytical lab in Brisbane

Vaxxas raises A$34M to clinicall advance needle-free vaccines

Vaxxas has completed a financing round which raised 23 million A$34 million) in new funds.

Merck, Kelun-Biotech ink $9.3B licensing pact for 7 cancer candidates in China

news about finance

Prejex joins hands with Polybond to make needle-less injections in India

Prejex Inc., a spin-off of Germany-based Prejex GMBH, has entered into an agreement with Polybond, headed by Adit Rathi of Rathi Group to manufacture needleless injections.

Thailand develops

speech recognition AI tech for screening depression

Australian first research

trial to explore use of psychedelics for alcohol use disorder

AstraZeneca India

appoints Dr Sanjeev Panchal as Country President MD

One Health Trust BITS Pilani offer PhD

programme in Data Sciences for global health

NTU Singapore and Imperial College London strengthen ties

Building on their successful collaboration in setting up the Lee Kong Chian School of Medicine LKCMedicine), Nanyang Technological University, Singapore NTU Singapore) and Imperial College London have signed a new strategic university-wide partnership to expand their scope of collaboration across research, education, and innovation and enterprise.

Broad-impact Tech Against AMR Threat

According to one of the most comprehensive studies of antimicrobial resistance AMR), 95 million deaths were associated with including 1.27 million deaths attributed to bacterial AMR in 20109.

Al: Tremendous Potential to Transform Bioprocessing Efficiencies

The biopharmaceutical industry is witnessing unprecedented growth, with a surge in demand for vaccines, monoclonal antibodies mAbs), and advanced modalities including RNA therapeutics, mRNA vaccines, and cell and gene therapies CGTs).

Propelling Genomic Research with Future-Proof Digital Infrastructure

Digital transformation in healthcare has been D at breakneck speed since the outbreak of the COVID-109.

“We are seeing activity within biotherapeutics market in Southeast Asia’

Jason Neo, Director, Marketing J-KOSEA, SCIEX, Singapore

“Our ambition requires us to take long-term view, investing in scale and building unmatched capabilities”

The novel trend in single-cell analysis is revolutionising biological research, unravelling underlying genetic credentials while creating new therapeutic approaches and personalised treatments.

‘Innovations that serve a purpose, paired with a good go-to-market Strategy are attractive for VCs"

Singapore’s health and biomedical landscape constitutes a vibrant pool of innovative medical technology, biotechnology and biopharmaceutical entrepreneurship.

“Crovalimab could potentially become the first global drug originating from Singapore”

There has been explosive growth in the mid- size molecules and therapeutic antibody market as many cancers, autoimmune diseases, metabolic diseases, and infectious diseases have been successfully treated.

New Zealand explores

ways to improve clinical trials

Singapore injects

1M into Global Fund for fighting AIDS, malaria and TB

Japan approves manufacturing and marketing of Adtralza for atopic dermatitis

Denmark-based LEO Pharma A/S, a global leader in medical dermatology, has announced that the Japan Ministry of Health, Labour and Welfare (MHLW) has granted approval for the manufacturing and marketing of Adtralza (tralokinumab) subcutaneous injection

Korea, Singapore strengthen bilateral cooperation over digital health medical devices

South Korean Ministry of Food and Drug Safety (MFDS) recently held a bilateral meeting with the Health Sciences Authority (HSA) of Singapore at Seoul to support the advancement of domestic medical devices into the global market and strengthen bilateral cooperation in the field of digital health medical devices

India Discovers 3 Antiviral Molecules For Treating COVID-19

A team of researchers at Indian Institute of Technology (IIT) Roorkee has identified antiviral molecules that can be used effectively to treat COVID-19 infections.

PerkinElmer launches industry-first readyto-use viral vector assays

PerkinElmer, Inc. has launched ready-to-use Adenoassociated Virus Vectors (AAV) Detection Kits to support researchers working on gene therapies for a variety of serious diseases.

Agilent, Monash University collaborate to build Malaysia Integrated Biology Centre

Agilent Technologies has entered a new strategic partnership with Monash University Malaysia (Monash) to build a Malaysia integrated biology centre

Nikon enters into Indian healthcare sector through microscopy biz

Nikon India has announced its foray into India’s healthcare sector through System Product Microscopy business.

Sartorius enters research partnership with The BASE Facility at University of Queensland

Germany-based Sartorius has entered a research partnership with The BASE Facility at The University of Queensland (UQ), Australia to improve the manufacturing process of nucleic acid products led by the external collaboration group, Separation Separation Technology Marketing team.

Singapore links air polluting particles with cardiac arrests

Small particles in air pollution in Singapore might have caused sudden cardiac arrests in some people who were not in hospital but simply going about their normal lives, according to scientists at Duke-NUS Medical School working with the National Environment Agency (NEA) as part of the PanAsian Resuscitation Outcomes Study (PAROS).

New Zealand explores genomic sequencing to improve newborns' well-being

Researchers from the University of Auckland’s Liggins Institute in New Zealand are about to harness the technology of rapid genome sequencing in the hope of improving the well-being of critically ill newborn babies.

Hong Kong uses novel computation methods to develop COVID-19 hotspot map

A research team led by Hong Kong Baptist University (HKBU) has launched the Hong Kong COVID-19 Hotspot Map which allows the intuitive visualisation of real-time and dynamic geographic distribution of COVID-19 cases in Hong Kong.